Arcline to Sell Medical Manufacturing Technologies to Perimeter Solutions for $685 Million

Arcline Investment Management has announced a significant transaction, agreeing to sell its portfolio company, Medical Manufacturing Technologies (MMT), to Perimeter Solutions, Inc. for $685 million. This deal marks a pivotal shift for both companies and is set to close in the first quarter of 2026, pending regulatory approvals and other customary conditions.

MMT, headquartered in Charlotte, North Carolina, is a prominent global provider specializing in medical device manufacturing solutions. The company acts as a partner for over 1,000 clients, including leading Original Equipment Manufacturers (OEMs) and Contract Development and Manufacturing Organizations (CDMOs), executing the production of complex interventional medical devices such as catheters, guidewires, stents, and microcoils. With a workforce of more than 350 employees and a network of 14 production facilities, MMT is essential for clients that require precision in highly regulated environments.

Since Arcline's acquisition of MMT in 2020, the private equity firm has implemented a strategic plan to expand the company's capabilities and enhance its service offerings. Notably, Arcline's efforts have led to increased revenue and EBITDA for MMT, alongside 13 targeted acquisitions that have enriched the company’s portfolio in automation solutions and specialty manufacturing services.

Arcline's CEO, Robbie Atkinson, along with the entire MMT team, has been credited with the company's successful growth trajectory. William Blair and Houlihan Lokey served as financial advisors for the transaction, while Kirkland & Ellis LLP and Fredrikson & Byron P.A. were the legal advisors to Arcline. This sale aligns with Arcline’s strategy to cultivate robust industrial platforms capable of sustained, long-term growth.

Arcline Investment Management's decision to sell Medical Manufacturing Technologies (MMT) to Perimeter Solutions for $685 million presents an important moment for investors analyzing the medical manufacturing sector. This transaction, indicative of Arcline's successful growth strategy post-2020, raises several points of interest for potential investors and stakeholders.

MMT's established reputation as a provider of complex medical device manufacturing solutions, especially in the production of critical medical devices needed in highly regulated environments, positions it favorably within the market. The company has demonstrated strong performance through strategic growth initiatives that included significant revenue and EBITDA enhancements, alongside 13 targeted acquisitions. This reflects a robust investment thesis and exemplifies the appeal of well-executed acquisition strategies in the medical manufacturing space.

Perimeter Solutions’ acquisition of MMT allows it to expand into a segment characterized by increasing demand for advanced medical technologies. For investors in Perimeter, this acquisition could lead to enhanced market share and diversification of its product offerings, positioning the company well within a sector that continues to grow in response to technological advancements and rising healthcare demands.

However, for investors evaluating Arcline's future pathways, it is critical to assess how the sale aligns with its plan to continue building non-disruptible industrial platforms. With over $20 billion in assets under management, Arcline's long-term growth strategy could benefit from reinvesting the proceeds from this sale into new investments that promise similar growth trajectories.

Given the dynamics involved, market participants should closely watch regulatory approvals and the integration of MMT into Perimeter's operations. While the sale signals a successful exit for Arcline, it also invites analysis on the future growth potential of both companies. Investors holding stocks in either firm should consider their positions carefully as these developments unfold.